1. Chemosensitization of Cancer In vitro and In vivo by Nitric Oxide Signaling
   Lisa J. Frederiksen et al, 2007, Clinical Cancer Research CrossRef
2. Potential mechanisms of cancer-associated fibroblasts in therapeutic resistance
   Zehua Zhao et al, 2023, Biomedicine & Pharmacotherapy CrossRef
3. A co-delivery nanosystem of chemotherapeutics and DNAzyme overcomes cancer drug resistance and metastasis
   Shu-Pin Sun et al, 2017, Nano Futures CrossRef
4. Characterization of a New Antibody Raised against the NH2 Terminus of P-Glycoprotein
   Prema S. Rao et al, 2005, Clinical Cancer Research CrossRef
5. Role of ZEB Family Members in Proliferation, Metastasis, and Chemoresistance of Prostate Cancer Cells: Revealing Signaling Networks
   Leyla soleymani et al, 2021, Current Cancer Drug Targets CrossRef
6. The effect of ciprofloxacin on doxorubicin cytotoxic activity in the acquired resistance to doxorubicin in DU145 prostate carcinoma cells
   Asieh Davary Avareshk et al, 2022, Medical Oncology CrossRef
7. Rational Identification of Hsp90 Inhibitors as Anticancer Lead Molecules by Structure Based Drug Designing Approach
   Sayan D. Gupta et al, 2020, Anti-Cancer Agents in Medicinal Chemistry CrossRef
8. A Triphenylphosphonium-Functionalized Mitochondriotropic Nanocarrier for Efficient Co-Delivery of Doxorubicin and Chloroquine and Enhanced Antineoplastic Activity
   Katerina Panagiotaki et al, 2017, Pharmaceuticals CrossRef
9. Direct Intranuclear Anticancer Drug Delivery via Polydimethylsiloxane Nanoparticles: in Vitro and in Vivo Xenograft Studies
   Gargi Mishra et al, 2017, ACS Applied Materials & Interfaces CrossRef
10. Androgen Receptor Splice Variant 7 Drives the Growth of Castration Resistant Prostate Cancer without Being Involved in the Efficacy of Taxane Chemotherapy
    Yasuomi Shimizu et al, 2018, Journal of Clinical Medicine CrossRef